A
Abingworth Portfolio holdings
AUM
$307M
This Quarter Return
+11.03%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$120M
AUM Growth
+$120M
(+15%)
Cap. Flow
+$40M
Cap. Flow
% of AUM
33.41%
Top 10 Holdings %
Top 10 Hldgs %
93.81%
Holding
21
New
1
Increased
2
Reduced
2
Closed
4
Top Buys
1 |
CRISPR Therapeutics
CRSP
|
$52M |
2 |
Ocugen
OCGN
|
$1.15M |
3 |
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
|
$476K |
Top Sells
1 |
CEMP
Cempra, Inc.
CEMP
|
$9.29M |
2 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$1.75M |
3 |
Aurinia Pharmaceuticals
AUPH
|
$1.38M |
4 |
RGLS
Regulus Therapeutics
RGLS
|
$1.08M |
5 |
Achieve Life Sciences
ACHV
|
$195K |
Sector Composition
1 | Healthcare | 93.67% |
2 | Technology | 1.15% |